ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

RR vs TMO // EV/EBITDA & P/E VALUATION

Richtech Robotics Inc. (Class B) (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: RR 2 — TMO 8
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RR VS. TMO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC RR TMO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 35.90% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -6.70% 9.30% -16.00 TMO /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — 30.4x — TIE /valuation <GO>
Free Cash Flow Yield -5.95% 2.40% -8.35 TMO /fcf-yield <GO>
Operating Margin -60.00% 17.40% -77.40 TMO /operating-margins <GO>
Net Profit Margin -60.00% 15.10% -75.10 TMO /net-margins <GO>
Revenue Growth (YoY) 19.00% 3.90% +15.10 RR /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.24% -0.24 TMO /dividend-safety <GO>
Altman Z-Score & Debt/Equity 19.98 4.50 +15.48 RR /balance-sheet <GO>
Piotroski F-Score Quality 5/9 8/9 -3.00 TMO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 19.4 62.9 -43.52 TMO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 0.94 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 36.3x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $236.4M $262.22B -$261.98B TMO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR RR REV TMO REV RR GROSS % TMO GROSS % RR FCF TMO FCF
FY 2025 $5.0M $44.56B 35.9% — -$14.1M $6.29B
FY 2024 $4.2M $42.88B 63.7% — -$5.8M $7.27B
FY 2023 $8.8M $42.86B — — -$2.9M $6.48B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RR // BETA —
TMO // BETA 0.94